Bulevirtide-impurities | Pharmaffiliates

Bulevirtide

Bulevirtide is indicated for the treatment of chronic hepatitis delta virus (HDV) infection in plasma (or serum) HDV-RNA positive adult patients with compensated liver disease. Reference standards of Bulevirtide API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

stdClass Object
(
    [pname] => Bulevirtide - API Standards 
    [catalogue_number] => PA 02 2450000
    [category_ids] => ,70,78,82,97,114,
    [chemical_name] => 
    [weight] => NA
    [form] => NA
    [cas] => 2012558-47-1
    [pslug] => 2012558-47-1-bulevirtide-api-pa022450000
    [latest_product] => 0
    [linkproducts] => 0
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)
PA 02 2450000

Bulevirtide - API Standards


  • Catalogue No.:PA 02 2450000

  • CAS :

    2012558-47-1

  • Molecular Formula : NA

  • Molecular Weight : NA